Pharmaceutical major Abbott India Ltd will establish a nutrition research and development centre in India in collaboration with Syngene.
Syngene, a subsidiary of Biocon, is in engaged in contract research.
The R&D centre would focus on development of “science-based, affordable nutrition products’’ and enable the expansion of Abbott’s nutrition product portfolio, both the companies said in their joint statement to the stock exchanges today.
More than 50 researchers and scientists would be based at the centre to be located at Biocon Park in Bangalore. The centre is likely to be opened in June.
The centre will focus on the development of nutrition products for maternal and child nutrition and diabetes care. Among the products being developed for the Indian market are meal complements for diabetics and pre-diabetics.
In addition, the centre will address local taste and texture preferences with new flavours and formulations, the statement added.